Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics.
Read more about cookies
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities
mei 2023
Irene, Paassen, et al
Oncogene
Multi-dimensional profiling of hepatoblastomas and patient-derived tumor organoids uncovers tumor subpopulations with divergent WNT activation profiles and identifies pan-hepatoblastoma drug sensitivities
jan. 2023
Thomas, Kluiver, et al
bioRxiv
Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment
feb. 2022
Christian K, Hirt, et al
Cell genomics
EWSR1-WT1 Target Genes and Therapeutic Options Identified in a Novel DSRCT In Vitro Model
dec. 2021
Margit, Bleijs, et al
Cancers 2021, 13(23), 6072
The H3.3K27M oncohistone affects replication stress outcome and provokes genomic instability in pediatric glioma
